Skip to main navigation Skip to search Skip to main content

A randomized, placebo-controlled, double-blind Phase 3 study to evaluate the efficacy, safety and tolerability of votoplam in participants with Huntington's Disease

Project: Research

Project Details

StatusActive
Effective start/end date01/29/26 → 02/2/29

Funding

  • Novartis Pharmaceuticals Corporation: $15,000.00